Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
AXON$422.00+7.40(+1.78%)Axon Announces Body 5: Next-Generation Camera Built for the AI Era Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more...[1:00:00 PM ET]PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]

IONQ · NYSE

IonQ, Inc.

$31.19 +0.23 (+0.74%)

Company overview

IonQ, Inc. engages in the development of general-purpose quantum computing systems. It sells access to quantum computers with 20 qubits. The company makes its quantum computers accessible through cloud platforms, including Amazon Web Services' (AWS) Amazon Braket, Microsoft's Azure Quantum, and Google's Cloud Marketplace, as well as through its own cloud service. IonQ, Inc. was founded in 2015 and is headquartered in College Park, Maryland.

Sector
Technology
Industry
Computer Hardware
Exchange
NYSE
Market cap
$12.6B
Employees
407
Headquarters
College Park, MD
Website
ionq.com
CEO
Niccolo Mcleod de Masi
Listed
January 4, 2021
P/E
346.56
Dividend yield
0.00%

Company financials

Revenue
$187M
Gross profit
$71.3M
Operating income
-$830M
EBITDA
-$677M
Net income
$277M
EPS
$0.09
Total assets
$6.7B
Total debt
$30.4M
Gross margin
38.08%
Net margin
148.08%
Earnings yield
0.29%

Revenue segmentation

By product (FY 2025)

No product segmentation.

By region (FY 2025)

Showing FY 2025

Price chart

28.2940.0651.8463.6275.39
IONQ 1D NYSE O30.92H31.58L30.38C31.27+0.11 (+0.35%)Vol13.09M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
IONQ Stock news Prediction: 2 Stocks That Will Be Worth More Than IonQ 5 Years From Now The Motley Fool
IONQ Stock news Here is What to Know Beyond Why IonQ, Inc. (IONQ) is a Trending Stock Zacks Investment Research
IONQ Stock news IonQ vs. Rigetti Computing: Which Quantum Computing Stock Is the Better Buy? The Motley Fool
IONQ Stock news IonQ to Report Third Quarter 2026 Financial Results on November 5, 2026 Business Wire
IONQ Stock news Is IonQ a Millionaire-Maker Stock? The Motley Fool
IONQ Stock news IonQ Is Now Down 24% in a Month: Is IONQ a Toxic Stock or Ready for a Recovery? 24/7 Wall Street
IONQ Stock news Prediction: Here's What a $1,000 Investment in IonQ Stock Could Be Worth in 5 Years The Motley Fool
IONQ Stock news Forget the Anthropic IPO. Here Are 6 Stocks Worth Watching. The Motley Fool
IONQ Stock news IonQ, Rigetti Computing, D-Wave Quantum, and Quantum Computing Inc. Are Shaking Wall Street to Its Core With This $1 Billion Warning The Motley Fool
IONQ Stock news If I Could Only Buy 1 Quantum Computing Stock With $1,000, It Would Be This One. Fool - Investing News
IONQ Stock news IonQ, Inc. (IONQ) Stock Dips While Market Gains: Key Facts Zacks Investment Research
IONQ Stock news Can IonQ's $1.3B Elisity Deal Address Quantum-Era Security Threats? Zacks Investment Research
IONQ Stock news Quantinuum vs. IonQ: Why One Major Wall Street Firm Says This Stock Is the Better Bet The Motley Fool
IONQ Stock news Prediction: IonQ Could 10x by 2035 The Motley Fool
IONQ Stock news Quantum Computing Stocks To Follow Now – October 16th Defense World
IONQ Stock news Quantum Computing Is Still Years Away. These 6 Stocks Show Who Is Closest to Real Revenue. The Motley Fool
IONQ Stock news IonQ (IONQ) Soars 9.3%: Is Further Upside Left in the Stock? Zacks Investment Research
IONQ Stock news Massive News for IonQ Stock Investors The Motley Fool
IONQ Stock news Prediction: IonQ Will Cross $100 Per Share in 2027 (It's Less Than $40 Per Share Now) The Motley Fool
IONQ Stock news IonQ Is Following Nvidia's Playbook. Why the Stock Could Be a Buy After a 60% Dip. The Motley Fool
See more
FAQ

Questions about IonQ, Inc.

What does IonQ, Inc. do?
IonQ, Inc. engages in the development of general-purpose quantum computing systems. It sells access to quantum computers with 20 qubits. The company makes its quantum computers accessible through cloud platforms, including Amazon Web Services' (AWS) Amazon Braket, Microsoft's Azure Quantum, and Google's Cloud Marketplace, as well as through its own cloud service. IonQ, Inc. was founded in 2015 and is headquartered in College Park, Maryland.
What is IONQ's market cap?
IonQ, Inc. (IONQ) is a listed stock with a live quote. The latest market cap on this page is $12.6B.
Where is IonQ, Inc. headquartered?
IonQ, Inc. is headquartered in College Park, MD.
How do I get IONQ news from the API?
Call GET /v1/news?tickers=IONQ. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does IONQ news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for IONQ, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the IONQ price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs